Skip to Main Content

Author Details

Stephen J Freedland
Cedars-Sinai Medical Center
1996
725
80
PMIDPaper TitleJournal TitlePublished Year
36600045Concurrent prognostic utility of lymph node count and lymph node density for men with pathological node-positive prostate cancer.Prostate Cancer Prostatic Dis2024
38082056The effects of glycemic index on prostate cancer progression in a xenograft mouse model.Prostate Cancer Prostatic Dis2024
37964070Genetic and biological drivers of prostate cancer disparities in Black men.Nat Rev Urol2024
37917591A Proposal for the Comprehensive Care of Men on Androgen Deprivation Therapy: Recommendations From the Multidisciplinary Prostate Cancer 360 Working Group.Urol Pract2024
37890125Disparities With Systemic Therapies for Black Men Having Advanced Prostate Cancer: Where Do We Stand?J Clin Oncol2024
37783836Real-world treatment patterns and overall survival among men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) in the US Medicare population.Prostate Cancer Prostatic Dis2024
37873943Serum Testosterone and Dihydrotestosterone and Incidence and Progression of Lower Urinary Tract Symptoms: Results From the REDUCE Study.J Urol2024
37679602Biochemical recurrence in patients with prostate cancer after primary definitive therapy: treatment based on risk stratification.Prostate Cancer Prostatic Dis2024
37679601Application of next-generation imaging in biochemically recurrent prostate cancer.Prostate Cancer Prostatic Dis2024
37422525Investigating trends in interest for benign prostatic hyperplasia surgery options using Google Trends.Prostate Cancer Prostatic Dis2024
35039605Real-world evidence of patients with metastatic castration-resistant prostate cancer treated with cabazitaxel: comparison with the randomized clinical study CARD.Prostate Cancer Prostatic Dis2023
37966506A US real-world study of treatment patterns and outcomes in localized or locally advanced prostate cancer patients.World J Urol2023
37592001The impact of race on survival in metastatic prostate cancer: a systematic literature review.Prostate Cancer Prostatic Dis2023
37905039ONECUT2 Activates Diverse Resistance Drivers of Androgen Receptor-Independent Heterogeneity in Prostate Cancer.bioRxiv2023
37851874Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer.N Engl J Med2023
37587090The growing implications of obesity for prostate cancer risk and mortality: where do we go from here?J Natl Cancer Inst2023
37646326Plain language summary: Does the amount of time it takes for prostate-specific antigen to double affect how long men with nonmetastatic castration-resistant prostate cancer live and their healthcare costs?Future Oncol2023
37679603Relative search popularity of five advanced prostate cancer medications using Google Trends.Prostate Cancer Prostatic Dis2023
37969776Are higher follicle-stimulating hormone levels before androgen deprivation therapy for prostate cancer associated with oncological and cardiac outcomes and overall survival?-a population-level analysis.Transl Androl Urol2023
37531024Healthcare Costs in Men with Metastatic Castration-Resistant Prostate Cancer: An Analysis of US Medicare Fee-For-Service Claims.Adv Ther2023
35668181Validation of the prostate cancer comorbidity index in predicting cause-specific mortality in men undergoing radical prostatectomy.Prostate Cancer Prostatic Dis2023
36959101Targeting Glutamine Metabolism in Prostate Cancer.Front Biosci (Elite Ed)2023
37218911The Streaming Web-Based Exercise at Home Study for Breast and Prostate Cancer Survivors: A Feasibility Study Protocol.Methods Protoc2023
36950913Editorial Comment.J Urol2023
37217694Prostate cancer is not just a man's concern - the use of PSA screening in transgender women.Nat Rev Urol2023
37119522Prostate Cancer in Transgender Women in the Veterans Affairs Health System, 2000-2022.JAMA2023
37009710Avocados: A Recipe for Good Guacamole or Lower Cancer Risk?Cancer Prev Res (Phila)2023
37405681Are associations between obesity and prostate cancer outcomes following radical prostatectomy the same in smokers and non-smokers? Results from the SEARCH Cohort.Cancer Causes Control2023
37305204Quality-of-life impact of interstitial cystitis and other pelvic pain syndromes.Front Pain Res (Lausanne)2023
37368398Exposure to Agent Orange and Risk of Bladder Cancer Among US Veterans.JAMA Netw Open2023
37070723Smoking and lower urinary tract symptoms in Reduction by Dutasteride of Prostate Cancer Events Trial.Prostate2023
37002380Can high-intensity interval training impact tumor suppression and inflammatory response in prostate cancer survivors?Prostate Cancer Prostatic Dis2023
37433430Impact of Asian Race on Prognosis in De Novo Metastatic Prostate Cancer.J Natl Compr Canc Netw2023
37198099The Impact of Blue Light Cystoscopy Use Among Nonmuscle Invasive Bladder Cancer Patients in an Equal Access Setting: Implications on Recurrence and Time to Recurrence.Clin Genitourin Cancer2023
37096737Time from biopsy to radical prostatectomy by race in an equal-access healthcare system: Results from the SEARCH cohort.Prostate2023
37031461A modeling study to estimate prostate cancer-specific mortality on active surveillance for men with favorable intermediate-risk prostate cancer: Results from the SEARCH cohort.Cancer Med2023
37294698Diabetes and Prostate Cancer Outcomes in Men with Nonmetastatic Castration-Resistant Prostate Cancer: Results from the SEARCH Cohort.Cancer Epidemiol Biomarkers Prev2023
36814112Seeing the unseen: how can we best identify transgender women within the Veterans Affairs healthcare system's electronic medical record?J Sex Med2023
36653258Reply to Sandra Patricia García Nader, Sebastián Peña Rodríguez, and Cesar Alejandro Diaz Ritter's Letter to the Editor re: Farnoosh Nik-Ahd, Andrew Jarjour, Jane Figueiredo, et al. Prostate-specific Antigen Screening in Transgender Patients. Eur Urol. 2023;83:48-54.Eur Urol2023
36517634Prostate-specific antigen response and clinical progression-free survival in Black and White men with chemotherapy-naïve metastatic castration-resistant prostate cancer treated with enzalutamide in a real-world setting.Prostate Cancer Prostatic Dis2023
36875555The 24-Hour Movement Paradigm: An integrated approach to the measurement and promotion of daily activity in cancer clinical trials.Contemp Clin Trials Commun2023
36842915Survival and Economic Impact of Rapid Prostate-Specific Antigen Doubling Time in Patients With Nonmetastatic Castration-Resistant Prostate Cancer.Clin Genitourin Cancer2023
36737259The impact of life expectancy on cost-effectiveness of treatment options for clinically localized prostate cancer.Urol Oncol2023
36732363Working hard or hardly working? A brief commentary of latest research on exercise and prostate cancer.Prostate Cancer Prostatic Dis2023
36732362A healthy diet, a healthy prostate? A brief commentary on the latest research on diet and prostate cancer.Prostate Cancer Prostatic Dis2023
36597731Statins and Cancer Prevention-Association Does Not Mean Causation.Cancer Prev Res (Phila)2023
36450931Metabolic syndrome is associated with aggressive prostate cancer regardless of race.Cancer Causes Control2023
36001744Food Sensitivities in a Diverse Nationwide Cohort of Veterans With Interstitial Cystitis/Bladder Pain Syndrome.J Urol2023
36306979The 17-Gene Genomic Prostate Score Test Is Prognostic for Outcomes After Primary External Beam Radiation Therapy in Men With Clinically Localized Prostate Cancer.Int J Radiat Oncol Biol Phys2023
36261588Plant-based diets to reduce prostate cancer risk and improve prostate cancer outcomes-ready for prime time?Prostate Cancer Prostatic Dis2023
  • 1 - 50 of 725

Recommended Authors

Sebastiaan Remmers
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Career Start Year 2018
Number of shared co-authors 9
Francesco Pellegrino
Urological Research Institute, IRCCS San Raffaele Hospital
Career Start Year 2012
Number of shared co-authors 7
Izak Faiena
Columbia University Medical Center
Career Start Year 2010
Number of shared co-authors 5
David R Ziehr
Brigham and Women's Hospital
Career Start Year 2010
Number of shared co-authors 5
Adam Kinnaird
University of Alberta
Career Start Year 2007
Number of shared co-authors 10
Mieke Van Hemelrijck
School of Cancer and Pharmaceutical Sciences, King's College London
Career Start Year 2007
Number of shared co-authors 14
Declan G Murphy
Peter MacCallum Cancer Centre, University of Melbourne
Career Start Year 2005
Number of shared co-authors 49
Jonathan L Wright
University of Washington Medical Center
Career Start Year 2005
Number of shared co-authors 40
Derya Tilki
Universitatsklinikum Hamburg-Eppendorf
Career Start Year 2004
Number of shared co-authors 70
Channing J Paller
Johns Hopkins University School of Medicine
Career Start Year 2004
Number of shared co-authors 36
Anne Y Warren
Cambridge University Hospitals National Health Service Foundation Trust
Career Start Year 2003
Number of shared co-authors 22
Jun Hyuk Hong
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 2002
Number of shared co-authors 4
Antonio Hurtado-Coll
University of British Columbia
Career Start Year 2002
Number of shared co-authors 28
Mark C Markowski
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Career Start Year 2001
Number of shared co-authors 28
Eleni Efstathiou
Houston Methodist Cancer Center
Career Start Year 2000
Number of shared co-authors 42
Vincent J Gnanapragasam
University of Cambridge
Career Start Year 1999
Number of shared co-authors 18
Danny Vesprini
University of Toronto, Canada Odette Cancer Centre
Career Start Year 1998
Number of shared co-authors 19
Niall M Corcoran
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1997
Number of shared co-authors 25
Inge M van Oort
Radboud University Medical Center
Career Start Year 1995
Number of shared co-authors 38
Louis Lacombe
CHU de Quebec-Universite Laval
Career Start Year 1994
Number of shared co-authors 24
Choung-Soo Kim
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 1993
Number of shared co-authors 12
Alexandre R Zlotta
University Health Network, Princess Margaret Cancer Center, University of Toronto
Career Start Year 1993
Number of shared co-authors 23
Byung Ha Chung
Yonsei University College of Medicine and Gangnam Severance Hospital
Career Start Year 1992
Number of shared co-authors 16
Raymond S Lance
Washington State University Elson S. Floyd College of Medicine
Career Start Year 1992
Number of shared co-authors 14
Marshall Scott Lucia
University of Colorado School of Medicine
Career Start Year 1991
Number of shared co-authors 14
Bruce Montgomery
Fred Hutchinson Cancer Center, University of Washington
Career Start Year 1990
Number of shared co-authors 45
Philip Cornford
Liverpool University Hospitals
Career Start Year 1988
Number of shared co-authors 15
Mark Frydenberg
Monash University
Career Start Year 1988
Number of shared co-authors 47
Armen Aprikian
McGill University Health Centre, McGill University
Career Start Year 1987
Number of shared co-authors 16
John Trachtenberg
University of Toronto, University Health Network
Career Start Year 1971
Number of shared co-authors 16

Collaborators

Gerald L Andriole
Co-authored papers 55
Alan W Partin
The Brady Urological Institute, Johns Hopkins University School of Medicine
Co-authored papers 30
Michael R Freeman
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Co-authored papers 23
Elai Davicioni
Veracyte Inc.
Co-authored papers 23
Robert B Den
Thomas Jefferson University Hospital
Co-authored papers 21
Robert Jeffrey Karnes
Mayo Clinic
Co-authored papers 20
Ashley E Ross
Northwestern University
Co-authored papers 19
Eric A Klein
Cleveland Clinic
Co-authored papers 19
Bruce J Trock
Johns Hopkins University School of Medicine
Co-authored papers 18
Edward M Schaeffer
Northwestern University Feinberg School of Medicine
Co-authored papers 18
Daniel E Spratt
University Hospitals Seidman Cancer Center, Case Western Reserve University
Co-authored papers 16
Edwin M Posadas
Cedars-Sinai Medical Center
Co-authored papers 15
Felix Y Feng
UCSF Medical Center-Mount Zion
Co-authored papers 14
Sungyong You
Cedars-Sinai Medical Center
Co-authored papers 14
Howard M Sandler
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Co-authored papers 14
David Elashoff
David Geffen School of Medicine at University of California los angeles
Co-authored papers 13
Paul L Nguyen
Brigham and Women's Hospital and Dana Farber Cancer Institute, Harvard Medical School
Co-authored papers 10
William B Isaacs
The Brady Urological Institute, The Johns Hopkins School of Medicine
Co-authored papers 9
Yang Liu
Veracyte inc.
Co-authored papers 8
Lee W Jones
Memorial Sloan Kettering Cancer Center
Co-authored papers 7
Lorelei A Mucci
Co-authored papers 7
Nicholas Erho
GenomeDx Biosciences Inc.
Co-authored papers 7
Mohammed Alshalalfa
University of Miami Miller School of Medicine/Sylvester Comprehensive Cancer Center
Co-authored papers 7
Brandon A Mahal
Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine
Co-authored papers 7
Bridget F Koontz
Duke University School of Medicine
Co-authored papers 6
Neil E Fleshner
University of Toronto
Co-authored papers 6
Devin N Patel
university of california san diego School of Medicine
Co-authored papers 6
Monique J Roobol
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Co-authored papers 6
Robert E Reiter
David Geffen School of Medicine at university of california los angeles
Co-authored papers 6
Beatrice S Knudsen
University of Utah
Co-authored papers 6
Release 1.2